Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic ‐phase chronic myeloid leukemia

European Journal of Haematology, EarlyView.

Source: European Journal of Haematology - May 23, 2018 Category: Hematology Authors: Shuichi Ota , Toshihiro Matsukawa , Satoshi Yamamoto , Shinichi Ito , Motohiro Shindo , Kazuya Sato , Takeshi Kondo , Kyuhei Kohda , Hajime Sakai , Akio Mori , Tohru Takahashi , Hiroshi Ikeda , Hiroyuki Kuro Source Type: research